The role of coronary artery calcification in metal-related cardiovascular disease

Arce Domingo-Relloso1, Katlyn E McGraw2, Irene Martinez-Morata2

  • 1Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA; Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY, USA; IE University School of Science and Technology, Madrid, Spain.

Environment International
|February 1, 2026
PubMed

Insights

Urinary metals like cadmium and zinc are linked to cardiovascular disease (CVD) risk, partly through changes in coronary artery calcification (CAC) over time. This finding may help in early CVD detection and prevention strategies.

Area of Science:

  • Environmental Health
  • Cardiovascular Disease Epidemiology
  • Toxicology

Background:

  • Metals in urine are linked to cardiovascular disease (CVD), but the exact mechanisms are not fully understood.
  • Coronary artery calcification (CAC) is a key indicator of atherosclerosis and a predictor of CVD events.
  • Longitudinal changes in CAC may mediate the relationship between metal exposure and CVD incidence.

Purpose of the Study:

  • To investigate the role of coronary artery calcification (CAC) trajectory as an intermediate pathway linking urinary metal exposure to incident cardiovascular disease (CVD).
  • To quantify the proportion of the association between specific metals and CVD mediated by longitudinal changes in CAC.

Main Methods:

  • Utilized data from 6,459 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) with longitudinal CAC measurements (2000-2019).
  • Measured baseline urinary concentrations of cadmium, cobalt, copper, uranium, tungsten, and zinc (2000-2002).
  • Employed causal inference with a path-specific effects approach for longitudinal mediation analysis, accounting for competing risks.

Main Results:

  • Significant mediation of the association between urinary cadmium, cobalt, copper, tungsten, zinc, and incident CVD through CAC trajectory was observed.
  • An interquartile range increase in cadmium was associated with 44 additional CVD cases per 100,000 person-years through CAC.
  • Approximately half of the association between urinary cadmium and CVD may be mediated by longitudinal CAC changes.

Conclusions:

  • Urinary metal exposure contributes to CVD risk, in part, through its impact on the progression of coronary artery calcification over time.
  • Findings highlight the potential of urinary metal levels and CAC monitoring for early CVD risk assessment and targeted prevention.
  • Specific metals, notably cadmium, demonstrate a substantial mediation effect via CAC trajectory, underscoring their role in CVD pathogenesis.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
451
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
269
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
373
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
693
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
573